Refine by
Preclinical Studies Articles & Analysis
84 articles found
In preclinical respiratory studies, traditional methods like plethysmography often require animal restraint and extensive acclimation, limiting their ability to capture dynamic respiratory changes. ...
The development of recombinant MGP protein has enabled researchers to study the molecular mechanisms of calcification control and evaluate therapeutic interventions in a variety of disease contexts. ...
The effectiveness of ELANE as an antimicrobial enzyme is supported by in vivo studies showing increased susceptibility to bacterial infections in ELANE-deficient models. ...
Tissue cross-reactivity studies play an essential role in the understanding of immune responses, particularly in the context of autoimmunity, transplant rejection, and vaccine development. ...
They allow researchers to: (1) Investigate Endocrine Mechanisms: Advanced analysis techniques help researchers study steroid hormone imbalances associated with various conditions, including cortisol dysregulation, reproductive disorders, and adrenal dysfunction in experimental models. ...
According to active collaboration with scientists and clinical experts, the company promotes innovation and speeds up laboratory discoveries to help preclinical practice. Through strategic partnerships, Alfa Cytology focuses on developing FAP-targeted therapies that provide advanced tools for researchers to revolutionize cancer treatment protocols. ...
Efficacy Evaluation Analysis ServiceThe efficacy evaluation analysis service encompasses a wide range of studies designed to assess the therapeutic effects of RDC drugs in preclinical models. This includes evaluating clinical endpoints, such as tumor size reduction and survival rates in animal studies. 6. Toxicity Study ...
Alfa Cytology has officially released its antibody-drug conjugates(ADCs) development services which demonstrates the dedication to fighting cancer through advanced treatment methods. Alfa Cytology, which stands at the forefront of oncology service provision in New York United States, has announced its sophisticated antibody-drug conjugates(ADCs) development services for cancer. The pioneering ...
Preclinical drug discovery represents a critical phase in the development of new therapeutics. ...
Animal models offer researchers valuable insights that cannot be obtained through in vitro studies alone, bridging the gap between laboratory research and human application. ...
“We are thrilled to provide researchers with access to advanced technologies and comprehensive services critical for their groundbreaking studies.” In summary, Alfa Cytology excels in delivering essential services for cancer immunotherapy research, enabling scientists and researchers to push the frontiers of existing knowledge and develop next-generation therapies. ...
Moreover, the services on ovarian cancer model development allow researchers to utilize state-of-the-art preclinical models that closely mimic human ovarian cancer biology. These models enable the in-depth study of tumor behavior and therapeutic response, facilitating the discovery of novel treatment avenues tailored to individual patient profiles. ...
The evaluation of cardiovascular toxicity is a significant challenge in drug development. Preclinical evaluation of cardiovascular safety involves a multifaceted approach, encompassing a plethora of in vitro and in vivo endpoints. These assessments continuously evolve, aiming to mitigate the incidence of cardiovascular toxicity that may emerge during clinical trials. To shed light on the ...
This ease of use has catalyzed numerous studies aimed at understanding gene function and the mechanisms underlying various diseases. Furthermore, it has led to accelerated timelines for preclinical and clinical trials, ultimately benefiting patients awaiting lifesaving therapies. ...
Importantly, Alfa Cytology’s team of experts guides scientists through the experimental landscape, assisting in drug formulation, validation studies, and clinical transition strategies. This inclusive service design guarantees the efficacy and safety of drugs for further applications, including preclinical trials and regulatory submission. ...
Hence, an extensive lattice of regulations envelops these modalities, mandating rigorous preclinical studies and clinical trials before their eventual public deployment. ...
Precision-Cut Lung Slices (PCLS) have emerged as a innovative ex vivo model that allows researchers to explore deep into lung physiology, disease mechanisms, and pharmacological responses. By offering a unique combination of biological complexity and controlled experimental conditions, PCLS serve as a critical bridge between the limitations of traditional in vitro cell cultures and the ...
Alfa Cytology’s team of scientists can design more effective vaccine programs, and conduct preclinical evaluations on the safety and efficiency of vaccines. Moreover, to further explore the mechanism of PC occurrence, development, invasion, and metastasis, Alfa Cytology independently developed PC model construction services, dedicated to offering different ...
Alfa Cytology has announced its small molecule drug development to advance preclinical cancer research. Alfa Cytology, a comprehensive biotech company specializing in cancer research, has recently announced the cancer small molecule drug development services. ...
Host cell proteins (HCPs) are protein impurities produced by genetically engineered strains or cell lines. Some of these proteins are necessary for the survival, reproduction and other normal physiological activities of engineered strains or cell lines. HCPs are purified together with the target product during the production process and cannot be removed. Risks of HCPs In general, HCP ...